Systematic review on toxicity outcomes of graphene oxide coated materials

Document Type : Review Paper

Authors

1 Department of General Pathology and Microbiology, Chandra Dental College and Hospital, Faizabad road, Dharsania, India

2 Department of Environment, Amity School of Applied Sciences, Amity University, Lucknow, India

10.22038/nmj.2025.75667.1837

Abstract

Graphene and its derived forms have surfaced as promising substances for a wide range of technological and biomedical purposes. However, it is crucial to evaluate their safety and potential risks to ensure their safe use. This systematic review examines the present state of knowledge regarding the toxicity of graphene oxide (GO) through in-vivo, in-vitro, and other species studies. The aim of this present research was to study toxicity outcomes of GO-coated materials. The literature search was conducted and most important electronic databases (20 studies) were checked and selected for the present study. The findings underscore the need for cautious consideration of GO’s potential risks, especially at high concentrations and prolonged exposures. Continued research efforts are essential to gain a deeper understanding of the underlying mechanisms and to develop appropriate safety guidelines for the utilization of GO in various applications.

Keywords


1.     Ou L, Song B, Liang H, Liu J, Feng X, Deng B, Sun T, Shao L. Toxicity of graphene-family nanoparticles: A general review of the origins and mechanisms. Part Fibre Toxicol. 2016;13:57.
2.    Seabra AB, Paula AJ, de Lima R, Alves OL, Durán N. Nanotoxicity of graphene and graphene oxide. Chem Res Toxicol. 2014;27(2):159-168.
3.    Graphene-Info the Graphene Expert. Graphene oxide: Introduction and market news [Internet]. Metalgrass LTD; 2019. Available from: https://www.graphene-info.com/graphene-oxide
4.    Priyadarsini S, Mohanty S, Mukherjee S, Basu S, Mishra M. Graphene and graphene oxide as nanomaterials for medicine and biology application. J Nanostructure Chem. 2018;8: 123-137.
5.    Anand A, Unnikrishnan B, Wei S, Chou C, Zhang L, Huang C. Graphene oxide and carbon dots as broad-spectrum antimicrobial agents - a minireview. J R Soc Chem. 2018;4:117-137.
6.    Sanchez VC, Jackhak A, Hurt RH, Kane AB. Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem Res Toxicol. 2012;25:15-34.
7.    Brodie BC. On the atomic weight of graphite. Philosophical Transactions of the Royal Society of London Series I. 1859; 149:249-259.
8.    Min SK, Kim WY, Cho Y, Kim KS. Fast DNA sequencing with a graphene-based nanochannel device. Nat Nanotechnol. 2011;6(3):162-165.
9.    Bianco A, Cheng HM, Enoki T, Gogotsi Y, Hurt RH, Koratkar N, Kyotani T, Monthioux M, Park CR, Tascon JM, Zhang J. All in the graphene family–A recommended nomenclature for two-dimensional carbon materials. Carbon. 2013; 65:1-6.
10.    Tarcan R, Todor-Boer O, Petrovai I, Leordean C, Astilean S, Botiz I. Reduced graphene oxide today. J Mater Chem C. 2020; 8:1198-1224.
11.    Hekmat A, Saso L, Lather V, Pandita D, Kostova I, Saboury AA. Recent advances in nanomaterials of group XIV elements of periodic table in breast cancer treatment. Pharmaceutics. 2022;14(12):2640.
12.    Rhazouani A, Gamrani H, El Achaby M, Aziz K, Gebrati L, Uddin MS, Aziz F. Synthesis and toxicity of graphene oxide nanoparticles: A literature review of in vitro and in vivo studies. BioMed Research International. 2021;2021(1):5518999.
13.    . Magne TM, de Oliveira Vieira T, Alencar LM, Junior FF, Gemini-Piperni S, Carneiro SV, Fechine LM, Freire RM, Golokhvast K, Metrangolo P, Fechine PB. Graphene and its derivatives: Understanding the main chemical and medicinal chemistry roles for biomedical applications. J Nanostructure Chem. 2022; 1-35.
14.    Mahdavi M, Rahmani F, Nouranian S. Molecular simulation of pH-dependent diffusion, loading, and release of doxorubicin in graphene and graphene oxide drug delivery systems. J Mater Chem B. 2016; 4(46):7441-7451.
15.    Wang Y, Li Z, Wang J, Li J, Lin Y. Graphene and graphene oxide: biofunctionalization and applications in biotechnology. Trends Biotechnol. 2011;29(5):205-212.
16.    Paredes JI, Villar-Rodil S, Martínez-Alonso A, Tascon JMD. Graphene oxide dispersions in organic solvents. Langmuir. 2008; 24:10560-10564.
17.    Chung C, Kim YK, Shin D, Ryoo SR, Hong BH, Min DH. Biomedical applications of graphene and graphene oxide. Acc Chem Res. 2013; 46(10):2211-2224.
18.    Wang Y, Li Z, Hu D, Lin CT, Li J, Lin Y. Aptamer/-graphene oxide nanocomplex for in situ molecular probing in living cells. J Am Chem Soc. 2010;132(27):9274-9276.
19.    Fisher C, Rider AE, Kumar S, Levchenko I, Han Z, Ostrikov K. Applications and nanotoxicity of carbon nanotubes and graphene in biomedicine. J Nanomat. 2012; 2012:315185.
20.    Liu S, Zeng TH, Hofmann M, Burcombe E, Wei J, Jiang R, Kong J, Chen Y. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. ACS Nano. 2011; 5:6971-6980.
21.    Cebadero-Dominguez Ó, Casas-Rodríguez A, Puerto M, Cameán AM, Jos A. In vitro safety assessment of reduced graphene oxide in human monocytes and T cells. Environ Res. 2023:116356.
22.    Hashemi MS, Gharbi S, Jafarinejad-Farsangi S, Ansari-Asl Z, Dezfuli AS. Secondary Toxic Effect of Graphene Oxide and Graphene Quantum Dots Alters the Expression of MiR-21 and MiR-29a in Human Cell Lines. Toxicol In Vitro. 2020; 65:104796.
23.    Hu L, Fu Y, Rong L, Yang X, Li Y, Wang L, Wu W. Evaluating the cytotoxicity of graphene oxide using embryonic stem cells-derived cells. J Biomed Mater Res A. 2020; 108(6):1321-1328. 
24.    Arbo MD, Altknecht LF, Cattani S, Braga WV, Peruzzi CP, Cestonaro LV, Göethel G, Duran N, Garcia SC. In vitro cardiotoxicity evaluation of graphene oxide. Mutat Res Genet Toxicol Environ Mutagen. 2019;841:8-13. 
25.    Ma J, Liu R, Wang X, Liu Q, Chen Y, Valle RP, Zuo YY, Xia T, Liu S. Crucial role of lateral size for graphene oxide in activating macrophages and stimulating pro-inflammatory responses in cells and animals. ACS Nano. 2015;9(10):10498-10515.
26.    Liu Y, Luo Y, Wu J, Wang Y, Yang X, Yang R, Wang B, Yang J, Zhang N . Graphene oxide can induce in vitro and in vivo mutagenesis. Sci Rep. 2013;3:3469.
27.    Zhang X, Hu W, Li J, Tao L, Wei Y. A comparative study of cellular uptake and cytotoxicity of multi-walled carbon nanotubes, graphene oxide, and nanodiamond. Toxicol Res. 2012;1(1):62-68.
28.    Rhazouani A, Gamrani H, Ed-Day S, Lafhal K, Boulbaroud S, Gebrati L, Fdil N, Faissal AZ. Sub-acute toxicity of graphene oxide (GO) nanoparticles in male mice after intraperitoneal injection: Behavioral study and histopathological evaluation. Food Chem Toxicol. 2023;171:113553.
29.    Cao Z, Su M, Wang H, et al. Carboxyl graphene oxide nanoparticles induce neurodevelopmental defects and locomotor disorders in zebrafish larvae. Chemosphere. 2021;270:128611.
30.    Zhang L, Ouyang S, Zhang H, et al. Graphene oxide induces dose-dependent lung injury in rats by regulating autophagy. Exp Ther Med. 2021;21(5):462.
31.    Zhao S, Wang Y, Duo L. Biochemical toxicity, lysosomal membrane stability and DNA damage induced by graphene oxide in earthworms. Environ Pollut. 2021;269:116225.
32.    Zhang AW, Zhang Y, Li X, Kang K, Akhtar YS, Sha SX, Gao LX. Ocular toxicity of reduced graphene oxide or graphene oxide exposure in mouse eyes. Exp Eye Res. 2018;174:59-69.
33.    Hashemi E, Akhavan O, Shamsara M, Daliri M, Dashtizad M, Farmany A. Synthesis and cyto-genotoxicity evaluation of graphene on mice spermatogonial stem cells. Colloids Surf B Biointerfaces. 2016;146:770-776.
34.    Han SG, Kim JK, Shin JH, et al. Pulmonary responses of Sprague-Dawley rats in single inhalation exposure to graphene oxide nanomaterials. BioMed Res Int. 2015;2015:376756.
35.    Foadin CST, Tchangnwa Nya F, Malloum A, Conradie J. Data of electronic, reactivity, optoelectronic, linear and non-linear optical parameters of doping graphene oxide nanosheet with aluminum atom. Data Brief. 2022;41:107840.
36.    Sood K, Kaur J, Singh H, Kumar Arya S, Khatri M. Comparative toxicity evaluation of graphene oxide (GO) and zinc oxide (ZnO) nanoparticles on Drosophila melanogaster. Toxicol Rep. 2019;6:768-778.
37.    Combarros RG, Collado S, Diaz M. Toxicity of graphene oxide on growth and metabolism of Pseudomonas putida. J Hazard Mater. 2016;310:246-252.
38.    Lv X, Yang Y, Tao Y, Jiang Y, Chen B, Zhu X, Cai Z, Li B. A mechanism study on toxicity of graphene oxide to Daphnia magna: Direct link between bioaccumulation and oxidative stress. Environ Pollut. 2018;234:953-959.
39.    Souza JP, Venturini FP, Santos F, Zucolotto V. Chronic toxicity in Ceriodaphnia dubia induced by graphene oxide. Chemosphere. 2018;190:218-224.
40.    Tu Y, Lv M, Xiu P, et al. Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets. Nat Nanotechnol. 2013;8:594-601.
41.    Gurunathan S, Kim JH. Synthesis, toxicity, biocompatibility, and biomedical applications of graphene and graphene-related materials. Int J Nanomedicine. 2016;11:1927.
42.    Xu S, Zhang Z, Chu M. Long-term toxicity of reduced graphene oxide nanosheets: Effects on female mouse reproductive ability and offspring development. Biomaterials. 2015;54:188-200.
43.    Jennifer M, Maciej W. Nanoparticle technology as a double-edged sword: cytotoxic, genotoxic and epigenetic effects on living cells. J Biomater Nanobiotechnol. 2013;4:53-63.
44.    Wu W, Yan L, Wu Q, Li Y, Li Q, Chen S, et al. Evaluation of the toxicity of graphene oxide exposure to the eye. Nanotoxicology. 2016;10(9):1329-1340.
45.    Chatterjee N, Eom HJ, Choi J. A systems toxicology approach to the surface functionality control of graphene-cell interactions. Biomaterials. 2014;35:1109-1127.
46.    Jaworski S, Sawosz E, Grodzik M, Winnicka A, Prasek M, Wierzbicki M, et al. In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cells. Int J Nanomedicine. 2013;8:413-420.
47.     Liu Y, Luo Y, Wu J, Wang Y, Yang X, Yang R, et al. Graphene oxide can induce in vitro and in vivo mutagenesis. Sci Rep. 2013;3:3469.
48.    Vallabani NV, Mittal S, Shukla RK, Pandey AK, Dhakate SR, Pasricha R, et al. Toxicity of graphene in normal human lung cells (BEAS-2B). J Biomed Nanotechnol. 2011;7(1):106-107.
49.    Hu W, Peng C, Lv M, Li X, Zhang Y, Chen N, Fan C, Huang Q. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS nano. 2011 May 24;5(5):3693-700.
50.    Zhang Y, Ali SF, Dervishi E, Xu Y, Li Z, Casciano D, Biris AS. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS nano. 2010 Jun 22;4(6):3181-6.
51.    Lv M, Zhang Y, Liang L, Wei M, Hu W, Li X, Huang Q. Effect of graphene oxide on undifferentiated and retinoic acid-differentiated SH-SY5Y cells line. Nanoscale. 2012;4(13):3861-6.
52.    Mittal S, Kumar V, Dhiman N, Chauhan LKS, Pasricha R, Pandey AK. Physico-chemical properties based differential toxicity of graphene oxide/reduced graphene oxide in human lung cells mediated through oxidative stress. Sci Rep. 2016;6:39512.
53.    Wang A, Pu K, Dong B, et al. Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells. J Appl Toxicol. 2013;33(10):1156-1164.
54.    Liao KH, Lin YS, Macosko CW, Haynes CL. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl Mater Interfaces. 2011;3(7):2607-2615.
55.    Lammel T, Boisseaux P, Fernandez-Cruz ML, Navas JM. Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2. Part Fibre Toxicol. 2013;10:27.
56.    Gurunathan S, Han JW, Eppakayala V, Kim JH. Green synthesis of graphene and its cytotoxic effects in human breast cancer cells. Int J Nanomedicine. 2013;8:1015-1027.
57.     Akhavan O, Ghaderi E, Akhavan A. Size-dependent genotoxicity of graphene nanoplatelets in human stem cells. Biomaterials. 2012;33:8017-8025.
58.    Schinwald A, Murphy FA, Jones A, MacNee W, Donaldson K. Graphene-based nanoplatelets: A new risk to the respiratory system as a consequence of their unusual aerodynamic properties. ACS Nano. 2012;6:736-746.
59.    Fako VE, Furgeson DY. Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity. Adv Drug Deliv Rev. 2009;61:478-486.
60.    Gollavelli G, Ling YC. Multi-functional graphene as an in vitro and in vivo imaging probe. Biomaterials. 2012;33:2532-2545.
61.    Wang K, Ruan J, Song H, et al. Biocompatibility of graphene oxide. Nanoscale Res Lett. 2011;6:8-15.
62.    Singh SK, Singh MK, Nayak MK, et al. Thrombus inducing property of atomically thin graphene oxide sheets. ACS Nano. 2011;5:4987-4996.
63.    Wang X, Podila R, Shannahan JH, et al. Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axis. Int J Nanomedicine. 2013;8:1733-1748.
64.    Duch MC, Budinger GR, Liang YT, et al. Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. Nano Lett. 2011;11(12):5201-5207.
65.    Yan L, Wang Y, Xu X, et al. Can graphene oxide cause damage to eyesight? Chem Res Toxicol. 2012;25:1265-1270.
66.    Wu Q, Yin L, Li X, Tang M, Zhang T, Wang D. Contributions of altered permeability of intestinal barrier and defecation behavior to toxicity formation from graphene oxide in nematode Caenorhabditis elegans. Nanoscale. 2013;5(20):9934-43.
67.    Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiological reviews. 2014;94(3):909-50.
68.    Murphy MP. How mitochondria produce reactive oxygen species. Biochemical journal. 2009;417(1):1-3.
69.    Akhavan O, Ghaderi E. Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano. 2010;4:5731-5736.
70.    Hu W, Peng C, Luo W, Lv M, Li X, Li D, Huang Q, Fan C. Graphene-based antibacterial paper. ACS Nano. 2010;4:4317-4323.
71.    Feng L, Liu Z. Graphene in biomedicine: opportunities and challenges. Nanomedicine. 2011;6:317-324.
72.    Sasidharan A, Panchakarla LS, Chandran P, Menon D, Nair S, Rao CNR, Koyakutty M. Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. Nanoscale. 2011;3:2461-2464.
73.    Liu S, Zeng TH, Hofmann M, et al. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. ACS Nano. 2011;5:6971-6980.
74.    Soundarajan S, Rajasekar A. Antibacterial and anti-inflammatory effects of a novel herb-mediated nanocomposite mouthwash in plaque-induced gingivitis: a randomized controlled trial. Dental and Medical Problems. 2023;60(3):445-51.
75.    Sevagaperumal A, Lakshmi MG, Piriyanga RR, Priyadharshini SS, Abirami AA, Sherwood IA. Comparing the antimicrobial properties of graphene oxide silver nanoparticles as a root canal irrigant: A randomized controlled trial. Endodontology. 2024;36(1):16-24.
76.    Eskandari F, Abbaszadegan A, Gholami A, Ghahramani Y. The antimicrobial efficacy of graphene oxide, double antibiotic paste, and their combination against Enterococcus faecalis in the root canal treatment. BMC Oral Health. 2023;23(1):20.
77.    Andrews JP, Joshi SS, Tzolos E, Syed MB, Cuthbert H, Crica LE, Lozano N, Okwelogu E, Raftis JB, Bruce L, Poland CA. First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses. Nature Nanotechnology. 2024:1-0.
78.    Zare P, Aleemardani M, Seifalian A, Bagher Z, Seifalian AM. Graphene oxide: opportunities and challenges in biomedicine. Nanomaterials. 2021;11(5):1083.